首页> 外文期刊>Journal of Clinical Microbiology >Soft Salt-Mannitol Agar–Cloxacillin Test: a Highly Specific Bedside Screening Test for Detection of Colonization with Methicillin-Resistant Staphylococcus aureus
【24h】

Soft Salt-Mannitol Agar–Cloxacillin Test: a Highly Specific Bedside Screening Test for Detection of Colonization with Methicillin-Resistant Staphylococcus aureus

机译:软盐甘露醇琼脂–氯唑西林试验:一种高特异性的床头筛查试验,用于检测耐甲氧西林的金黄色葡萄球菌的定植

获取原文
       

摘要

The early detection of colonization with methicillin-resistantStaphylococcus aureus (MRSA) of patients in intensive-care units is an essential step in the strategy for preventing MRSA epidemics. In this study, tubes containing soft salt-mannitol agar with cloxacillin (6 μg/ml) (SSMAC) were prepared for inoculation of clinical samples at patients’ bedsides by personnel of an intensive-care unit. A total of 1,914 swabs from different sample sites of 81 patients were dipped into SSMAC tubes, and after 24 h of incubation (in an incubator located near the intensive-care unit), an evident color change was considered by the intensive-care-unit personnel to be an MRSA alarm. Sixty-three (3.3%) SSMAC tubes were considered positive for MRSA, 1,827 (95.4%) were considered negative, and 24 (1.2%) were considered intermediate. Compared with values for parallel conventional surveillance cultures for MRSA, excluding tubes with intermediate results, the SSMAC test had a sensitivity of 72.7%, a specificity of 99.2%, a positive predictive value of 76.2%, and a negative predictive value of 99.0%. When intermediate tubes were considered positive, the corresponding values were 75.3, 98.2, 63.2, and 99.0%, respectively. The sensitivity and specificity values of the test to identify MRSA-colonized patients were 89.4 and 100%, respectively. Oropharyngeal and naris specimens were the most reliable samples for MRSA detection. False-negative results were frequent in bronchial aspirates with low (<103 to 106CFU/ml) MRSA counts. False-positive results were mainly due to methicillin-resistant Staphylococcus haemolyticus. The SSMAC tube is a useful, rapid, and inexpensive tool for the early identification of MRSA-colonized patients and, consequently, for the implementation of measures to prevent the spread of MRSA.
机译:重症监护病房中耐甲氧西林的金黄色葡萄球菌(MRSA)的定植是早期发现,是预防MRSA流行病策略的重要步骤。在这项研究中,准备了装有软盐甘露醇琼脂和氯西林(6μg/ ml)(SSMAC)的试管,以供重症监护病房的人员在患者床旁接种临床样品。将总共​​81位患者不同样本位的1,914支棉签浸入SSMAC管中,孵育24小时后(在重症监护室附近的培养箱中),重症监护室认为出现了明显的颜色变化人员将成为MRSA警报。六十三(3.3%)的SSMAC管被视为MRSA阳性,1,827(95.4%)被视为阴性,而24(1.2%)被视为中度。与不进行中间结果检测的试管相比,与常规并行MRSA常规监测培养相比,SSMAC检测的灵敏度为72.7%,特异性为99.2%,阳性预测值为76.2%,阴性预测值为99.0%。当将中间管视为阳性时,相应的值分别为75.3%,98.2%,63.2和99.0%。鉴定MRSA克隆患者的测试的灵敏度和特异性值分别为89.4和100%。口咽和鼻孔标本是用于MRSA检测的最可靠的样品。 MRSA计数低(<10 3 至10 6 CFU / ml)的支气管抽吸物经常出现假阴性结果。假阳性结果主要归因于耐甲氧西林的溶血性葡萄球菌。 SSMAC管是一种有用,快速且廉价的工具,可用于早期识别MRSA克隆的患者,因此,用于实施预防MRSA扩散的措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号